Lv4
530 积分 2023-06-12 加入
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
5小时前
已完结
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
1个月前
已完结
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results
1个月前
已完结
Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix
3个月前
已完结
Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma
3个月前
已完结
Potential markers that complement expression of CA125 in epithelial ovarian cancer
3个月前
已完结
Novel WRN Helicase Inhibitors Selectively Target Microsatellite Unstable Cancer Cells
4个月前
已完结
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
4个月前
已完结
Cancer incidence and mortality in China, 2022
4个月前
已完结
皖公网安备34019202002308
